NASDAQ: MIRAMira Pharmaceuticals Inc Stock Ownership - Who owns Mira Pharmaceuticals?
Insider buying vs selling
Have Mira Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Erez Aminov | Chief Executive Officer | 2025-08-29 | 62,500 | $1.37 | $85.63kBuy |
| Erez Aminov | Chief Executive Officer | 2024-11-20 | 44,590 | $1.27 | $56.63kSell |
| Erez Aminov | Chief Executive Officer | 2024-11-19 | 55,410 | $1.39 | $77.02kSell |
MIRA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MIRA insiders and whales buy or sell their stock.
MIRA Shareholders
What type of owners hold Mira Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| George Cappy | 15.10% | 2,879,318 | $4.18M | Insider |
| Erez Aminov | 4.43% | 844,700 | $1.22M | Insider |
| Brian Patrick McNulty | 3.51% | 670,000 | $971.50k | Insider |
| Cross Staff Investments Inc | 1.88% | 359,401 | $521.13k | Institution |
| Christopher C. Chapman Jr. | 1.05% | 200,000 | $290.00k | Insider |
| Adam Kaplin | 1.05% | 200,000 | $290.00k | Insider |
| Geode Capital Management LLC | 0.71% | 135,295 | $196.18k | Institution |
| Vanguard Group Inc | 0.62% | 117,824 | $170.84k | Institution |
| Suncoast Equity Management | 0.54% | 103,289 | $149.77k | Institution |
| Bradley Kroenig | 0.26% | 50,000 | $72.50k | Insider |
MIRA vs General Drug Manufacturer Stocks
Mira Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.